MASS

908 Devices Inc

MASS, USA

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as process fingerprint data to support large-scale efforts in predictive bioprocess modeling. The company's products comprise Maven, an on-line device for bioprocess monitoring and control; Trace C2, an on-line monitoring of methanol or ethanol and control of substrate feeding in fermentation processes; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

https://908devices.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
MASS
stock
MASS

Broadcom Stock (-11%): AI Margin Fears Trigger a Mass Distribution Event Trefis

Read more →
MASS
stock
MASS

Mastercard (MA) Soars 4.5% After the Bell: What Investors Should Know Before the Stock Market Opens on December 12, 2025 ts2.tech

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$10

Analyst Picks

Strong Buy

3

Buy

0

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Low

1.60

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-10.99 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-7.85 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-34.87 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.40

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 86.30% of the total shares of 908 Devices Inc

1.

Awm Investment Company Inc

(14.4099%)

since

2025/06/30

2.

ARK Investment Management LLC

(7.3389%)

since

2025/06/30

3.

ARK Genomic Revolution

(7.1702%)

since

2025/06/30

4.

State Street Corp

(6.3381%)

since

2025/06/30

5.

ARK Genomic Revolution ETF

(5.5023%)

since

2025/08/28

6.

BlackRock Inc

(4.9628%)

since

2025/06/30

8.

Vanguard Group Inc

(3.9659%)

since

2025/06/30

9.

Gm Advisory Group Inc

(3.2292%)

since

2025/06/30

10.

First Light Asset Management, LLC

(2.9585%)

since

2025/06/30

11.

Vanguard Total Stock Mkt Idx Inv

(2.1478%)

since

2025/07/31

12.

Geode Capital Management, LLC

(1.8251%)

since

2025/06/30

13.

iShares Russell 2000 ETF

(1.804%)

since

2025/08/31

14.

Marshall Wace Asset Management Ltd

(1.7979%)

since

2025/06/30

15.

Tao Capital Management LP

(1.5767%)

since

2025/06/30

16.

Morgan Stanley - Brokerage Accounts

(1.5359%)

since

2025/06/30

17.

Essex Investment Management Company, LLC

(1.3228%)

since

2025/06/30

18.

Sumitomo Mitsui Trust Group Inc

(1.1036%)

since

2025/06/30

19.

Amova Asset Management Americas, Inc

(1.0929%)

since

2025/06/30

20.

Bank of America Corp

(1.0065%)

since

2025/06/30

21.

Dimensional Fund Advisors, Inc.

(1.006%)

since

2025/06/30

22.

First Eagle Small Cap Opportunity I

(0.9872%)

since

2025/07/31

23.

Vanguard Institutional Extnd Mkt Idx Tr

(0.797%)

since

2025/07/31

24.

Fidelity Small Cap Index

(0.7662%)

since

2025/06/30

25.

Arnhold & S. Bleichroeder Advisers, LLC

(0.741%)

since

2025/06/30

26.

Schonfeld Strategic Advisors LLC

(0.6552%)

since

2025/06/30

27.

First Eagle US Small Cap Strategy

(0.6512%)

since

2025/06/30

28.

Charles Schwab Investment Management Inc

(0.6437%)

since

2025/06/30

29.

Mitsubishi UFJ Asset Management Co.,Ltd

(0.5889%)

since

2025/06/30

30.

iShares Russell 2000 Growth ETF

(0.5518%)

since

2025/08/31

31.

Fidelity Extended Market Index

(0.4048%)

since

2025/07/31

32.

Vanguard Russell 2000 ETF

(0.3619%)

since

2025/07/31

33.

Schwab US Small-Cap ETFâ„¢

(0.3544%)

since

2025/08/30

34.

DFA US Targeted Value I

(0.3538%)

since

2025/07/31

35.

SPDR® S&P Kensho Future Security ETF

(0.3216%)

since

2025/08/31

36.

1290 Essex Small Cap Growth I

(0.2975%)

since

2025/07/31

37.

Pleiades Small Cap Equity A

(0.2949%)

since

2025/06/30

38.

Dimensional US Targeted Value ETF

(0.2516%)

since

2025/08/29

39.

UBC Russell 3000 Index Trust - C

(0.2476%)

since

2025/06/30

40.

State St Russell Sm Cap® Indx SL Cl I

(0.2197%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.044

EPS Estimate

-0.13

EPS Difference

0.086

Surprise Percent

66.1538%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(1.5)
Momentum
Moderate Momentum(6)
Net Net
Not Undervalued (Net-Net)(3)
Quality
Low Quality Business(3)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.